Biospectra recalls
Biospectra appears in 1 official U.S. recall notice indexed by RecallRadar, most recently on 2026-10-14.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 1 |
|---|---|
| Published | 2026-10-14 |
| By agency | FDA Drug (1) |
| By classification | Class II (1) |
| By status | ongoing (1) |
| Distribution named in notices | CA |
Recalls
- Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
FDA Drug · Class II · 2026-10-14 · Biospectra
Reason: Failed stability specifications